RxNorm Semantic Concepts Index - 350
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "350".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 3500 | Diphenoxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 3500 | Diphenoxylate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 3500 | Diphenoxylate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 3500 | Diphenoxylate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 3500 | Diphenoxylate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 35007 | Putrescine carbamoyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35007 | Putrescine carbamoyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 35008 | Putrescine acetyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35008 | Putrescine acetyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 35009 | Putrescine oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35009 | Putrescine oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350141 | brewer's yeast allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 350141 | brewer's yeast allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 350141 | brewer's yeast allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 350173 | Musca domestica allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 350173 | Musca domestica allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 350180 | xenon 250 MIL | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350183 | ascorbic acid 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350184 | vitamin B12 0.0025 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350186 | pantothenic acid 7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350187 | riboflavin 1.6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350195 | mitoxantrone 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350195 | mitoxantrone 1 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350197 | sodium fluoride 12.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350198 | stannous fluoride 480 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350200 | D-biotin 0.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350201 | Escherichia coli 10000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350202 | Escherichia coli | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350203 | potassium chloride 1880 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350207 | copper sulfate 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350215 | liothyronine 0.0045 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350217 | dexamethasone 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350217 | dexamethasone 10 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350225 | adenine 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350255 | hepatitis nosodes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350262 | Cinchona officinalis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350273 | pantothenic acid 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350277 | ethinyl estradiol 0.003 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 35028 | Pranoprofen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35028 | Pranoprofen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350282 | pyridoxine hydrochloride 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 35029 | Glucose 2-oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 35029 | Glucose 2-oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35029 | Glucose 2-oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 35030 | Parathiazine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 35030 | Parathiazine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35030 | Parathiazine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350301 | stannous fluoride 12.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350305 | PHENobarbital 102 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350305 | PHENobarbital 102 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350310 | Mucor racemosus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350312 | Aspergillus niger preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350320 | niacinamide 17 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350329 | cupric oxide 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350331 | benzalkonium 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350341 | beta carotene 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350344 | Conium preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350374 | betaine, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 350376 | Sepia extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350382 | biotin 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350383 | papain 190 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350384 | urea 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350385 | trichloroacetic acid 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350386 | Mandragora officinarum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350400 | pancreatin 196 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350401 | niacin 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350421 | iron carbonyl 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350450 | chlorhexidine 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350458 | ferrous fumarate 460 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350459 | aspirin 428 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350460 | aspirin 856 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350463 | beta carotene 2700 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350465 | 1-alpha-vitamin D | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350466 | histamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 350469 | vitamin B6 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350480 | sodium fluoride 12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350481 | doxycycline 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350487 | norgestimate 0.09 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350488 | Serenoa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350489 | Viscum album preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350490 | Urtica dioica preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350491 | amylase 6000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350499 | biotin 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350500 | calcium pantothenate 27.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350501 | folic acid 0.904 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350502 | magnesium oxide 8.29 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350503 | vitamin E 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350509 | Viscum album preparation 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350510 | amylase 3000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350512 | sirolimus 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350513 | amylase 58500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350517 | lamotrigine 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350517 | lamotrigine 2 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 350520 | Carduus marianus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350528 | sumbul | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350530 | Tussilago petasites | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350532 | luesinum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350533 | medorrhinum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 350534 | alpha tocopherol 30 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350535 | calcium carbonate 532 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350537 | riboflavin 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350539 | mannitol 170 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350542 | doxycycline 109 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350543 | doxycycline 54.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350544 | ascorbic acid 62 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350545 | calcium sulfate 763 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350546 | vitamin B12 1.32 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350547 | niacinamide 84 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350557 | beta carotene 3000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350560 | clonazePAM 0.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350560 | clonazePAM 0.125 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 350561 | valsartan 320 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350563 | dimethicone 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350565 | papain 11000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 35061 | Pyridinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35061 | Pyridinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350610 | valdecoxib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350611 | valdecoxib 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350625 | sodium fluoride 408 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350630 | ceftizoxime 1500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350631 | ALPRAZolam 0.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350631 | ALPRAZolam 0.4 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350632 | ALPRAZolam 0.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350632 | ALPRAZolam 0.8 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350633 | bicalutamide 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350637 | voriconazole 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350639 | desloratadine 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350640 | dutasteride 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350643 | voriconazole 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350648 | tegaserod 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350649 | tegaserod 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350650 | doxercalciferol 0.0025 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350652 | efavirenz 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350653 | lercanidipine 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350654 | aripiprazole 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350654 | aripiprazole 15 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 350655 | lamiVUDine 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350655 | lamiVUDine 300 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 350656 | celecoxib 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350661 | tretinoin 0.0004 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350662 | guaiFENesin 275 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350662 | guaiFENesin 275 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350663 | aripiprazole 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350663 | aripiprazole 10 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 350664 | aripiprazole 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350664 | aripiprazole 30 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 350666 | guaiFENesin 595 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350666 | guaiFENesin 595 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350668 | guaiFENesin 795 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350668 | guaiFENesin 795 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 350670 | aripiprazole 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350670 | aripiprazole 20 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 350671 | ezetimibe 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350672 | nitazoxanide 1200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350673 | atomoxetine 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350674 | atomoxetine 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350675 | atomoxetine 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350676 | atomoxetine 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350677 | atomoxetine 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 35069 | Pyridoxal dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35069 | Pyridoxal dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350708 | aminophylline 21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350709 | aminophylline 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350710 | benzoic acid 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350711 | amcinonide 0.001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350712 | amoxicillin 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350714 | capromab pendetide 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350715 | betamethasone 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 35072 | Pyridoxal oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35072 | Pyridoxal oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350720 | betamethasone 0.012 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350723 | budesonide 0.125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350724 | salmon calcitonin 200 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350727 | pancreatin 720 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350728 | bacitracin 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350729 | tyrothricin 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350755 | dihydro-alpha-ergocryptine 0.222 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350756 | dihydro-beta-ergocryptine 0.111 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350758 | tetanus toxoid vaccine, inactivated 1000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350767 | Peruvian balsam 87 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350768 | castor oil 788 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350769 | trypsin 0.12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350792 | darbepoetin alfa 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350793 | darbepoetin alfa 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350794 | darbepoetin alfa 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350795 | darbepoetin alfa 0.04 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350796 | darbepoetin alfa 0.06 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350797 | desoximetasone 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 3508 | Biphosphonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 3508 | Biphosphonate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 3508 | Biphosphonate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 3508 | Biphosphonate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 3508 | Biphosphonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 3508 | Biphosphonate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350800 | glucose 220 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350804 | ergocalciferol 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 35083 | Pyridoxin dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 35083 | Pyridoxin dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35083 | Pyridoxin dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 35084 | Pyridoxine phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35084 | Pyridoxine phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 35084 | Pyridoxine phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 35093 | Pyrimidine-nucleoside phosphorylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35093 | Pyrimidine-nucleoside phosphorylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 350932 | luteinizing hormone 150 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350934 | fulvestrant 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350939 | ganirelix 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350963 | levalbuterol 0.103 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350965 | meningococcal polysaccharide vaccine group W-135 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350966 | meningococcal polysaccharide vaccine group Y 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350967 | meningococcal group C polysaccharide 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 35097 | Pyrisuccideanol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 35097 | Pyrisuccideanol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 35097 | Pyrisuccideanol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 35097 | Pyrisuccideanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 35097 | Pyrisuccideanol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 350972 | moxifloxacin 1.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350973 | phenylbutazone 0.2 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350977 | pegfilgrastim 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350978 | sodium phosphate, monobasic 700 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350981 | salicylic acid 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350982 | salicylic acid 750 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350984 | stannous fluoride 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350985 | sodium fluoride 6.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350986 | sodium fluoride 0.125 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350988 | Sarracenia purpurea preparation 170 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 350990 | simethicone 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 350991 | sodium lactate 560 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |